Cardiovascular complications of pediatric chronic kidney disease

Pediatric Nephrology

Volumn 23, Issue 1, 2008, Pages 27-39

  Mitsnefes, Mark M ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Division of Nephrology and Hypertension   (United States)

Author keywords

Cardiovascular disease; Children; Chronic kidney disease; ESRD

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCITRIOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATE BINDING AGENT; VITAMIN D;

ARTERIOSCLEROSIS; ARTERY CALCIFICATION; ARTERY COMPLIANCE; ATHEROSCLEROSIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; EVIDENCE BASED MEDICINE; HEART DEATH; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIFESTYLE MODIFICATION; LOW FAT DIET; MALNUTRITION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT DURATION;

CALCINOSIS; CARDIOVASCULAR DISEASES; CHILD; CHRONIC DISEASE; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 37049036874     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0359-0     Document Type: Review

References (124)

1. National Kidney Foundation Task Force on Cardiovascular Disease (1998) Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Special report from the National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32(Suppl 3):1-121
2. U.S. Renal Data System: USRDS (2003) Annual Report. Bethesda, The National Institute of Diabetes and Digestive and Kidney Diseases. http://www.usrds.org
3. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-110
4. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int 61:621-629
5. McDonald SP, Craig JC; Australian and New Zealand Paediatric Nephrology Association (2004) Long-term survival of children with end-stage renal disease. N Engl J Med 350:2654-2662
6. Parekh RS, Carrol CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191-197
7. Maron BJ (2003) Sudden death in young athletes. N Engl J Med 349:1064-1074
8. Mitsnefes MM, Daniels SR, Schwartz SA, Khoury P, Meyer RA, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:892-898
9. Mitsnefes MM, Barletta GM, Dresner I, Chand DD, Geary D, Lin JJ, Patel H (2006) Severe left ventricular hypertrophy in long-term dialysis: The Midwest Pediatric Nephrology Consortium Study. Pediatric Nephrol 21:1167-1170
10. Chavers BM, Shuling L, Collins AJ, Herzog CA (2002) Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648-653
11. Mitsnefes MM, Ho P-L, McEnery PT (2003) Hypertension and progression of chronic renal insufficiency in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 14:2618-2622
12. Loirat C, Ehrich JH, Geerlings W, Jones EH, Landais P, Mallick NP, Margreiter R, Raine AE, Salmela K, Selwood NH (1994) Report on management of renal failure in children in Europe, XXIII, 1992. Nephrol Dial Transplant 7 (Suppl 1):26-40
13. Lerner GR, Warady BA, Sullivan EK, Alexander SR (1999) Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 13:404-417
14. Mitsnefes MM, Stablein D (2005) Hypertension in pediatric patients on long-term dialysis: A report of North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 45:309-315
15. National Kidney Foundation (2003) Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. K/DOQI guidelines. Am J Kidney Dis 41(Suppl 3):S22-S38
16. Querfeld U, Salusky IB, Nelson P, Fine RN (1988) Hyperlipidemia in pediatric patients undergoing peritoneal dialysis. Pediatr Nephrol 2:447-452
17. Querfeld U (1993) Disturbances of lipid metabolism in children with chronic renal failure. Pediatr Nephrol 7:749-757
18. Saland JM, Ginsberg H, Fisher EA (2002) Dyslipidemia in pediatric renal disease: Epidemiology, pathophysiology, and management. Curr Opin Pediatr 14:197-204
19. Smith JM, Ho PL, McDonald RA (2002) Renal transplant outcomes in adolescents: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 6:493-499
20. Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A (1994) Analysis of hypertension in children post renal transplantation - a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 8:570-573
21. Mitsnefes MM, Khoury PR, McEnery PT (2003) Early post transplant hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143:98-103
22. Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte HJ (2000) Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol 14:105-110
23. Milliner DS, Morgenstern BZ, Murphy M, Gonyea J, Sterioff S (1994) Lipid levels following renal transplantation in pediatric recipients. Transplant Proc 26:112-114
24. Chavers BM, Hardstedt M, Gillingham KJ (2003) Hyperlipidemia in pediatric kidney transplant recipients treated with cyclosporine. Pediatr Nephrol 18:565-569
25. Hanevold CD, Ho PL, Mitsnefes MM (2005) Obesity and long-term outcome in children and adolescents after renal transplantation: A report of North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatrics 115:352-356
26. Mitsnefes MM, Khoury P, McEnery PT (2002) Body mass index and allograft function in pediatric patients with renal transplantation. Pediatric Nephrol 17:535-539
27. Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Selhub J, Dworkin L, Rosenberg IH (1997) Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol 17:2554-2558
28. Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW (1998) Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97:138-141
29. Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW (2002) Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61:609-614
30. National Kidney Foundation (2001) K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease. Am J Kidney Dis 37 (Suppl 1):S182-S238
31. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE (2003) Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol 14:159-168
32. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO(4), Ca×PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131-2138
33. Stenvinkel P, Wanner C, Metzger T, Heimburger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C (2002) Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? Kidney Int 62:1791-1798
34. Pecoits-Filho R, Bárány B, Lindholm B, Heimbürger O, Stenvinkel P (2002) Interleukin-6 and its receptor is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684-1688
35. Panichi V, Maggiore U, Taccola D, Migliori M, Rizza GM, Consani C, Bertini A, Sposini S, Perez-Garcia R, Rindi P, Palla R, Tetta C (2004) Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol Dial Transplant 19:1154-1160
36. Yao Q, Axelsson J, Heimburger O, Stenvinkel P, Lindholm B (2004) Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. Minerva Urol Nefrol 56:237-248
37. Vaziri ND (2004) Oxidative stress in uremia: Nature, mechanisms, and potential consequences. Semin Nephrol 24:469-473
38. Zoccali C, Mallamaci F, Tripepi G (2004) Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 15:S77-S80
39. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358:2113-2117
40. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y (2002) Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13:1894-1900
41. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134-141
42. K/DOQI Workgroup (2005) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 (Suppl 3):S10-S15
43. NAPRTCS (2005) The NAPRTCS 2005 Annual Report. http://www.NAPRTCS.org
44. Neu AM, Ho PL, McDonald RA, Warady BA (2002) Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report. Pediatr Nephrol 17:656-663
45. Neu AM, Fivush BA, Warady BA, Watkins SL, Friedman AL, Brem AS, Goldstein S, Frankenfield DL (2003) Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients. Pediatr Nephrol 18:1172-1176
46. Warady BA, Ho M (2003) Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol 18:1055-1062
47. Chavers BM, Roberts TL, Herzog CA, Collins AJ, St Peter WL (2004) Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients. Kidney Int 65:266-273
48. U.S. Renal Data System (2003) The USRDS 2003 Annual Report: Atlas of end-stage renal disease in the United States. Pediatric ESRD. Am J Kidney Dis 42 (Suppl 5):129-141
49. Yorgin PD, Belson A, Sanchez J, Al Uzri AY, Sarwal M, Bloch DA, Oehlert J, Salvatierra O, Alexander SR (2002) Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 40:1306-1318
50. Kausman JY, Powell HR, Jones CL (2004) Anemia in pediatric renal transplant recipients. Pediatr Nephrol 19:526-530
51. Mitsnefes MM, Subat-Dezulovic M, Khoury PR, Goebel J, Strife CF (2005) Increasing incidence of anemia after kidney transplantation in children. Am J Transplant 5:1713-1718
52. Merouani A, Delvin EE, Genest J Jr, Rozen R, Lambert M (2002) Plasma homocysteine concentration changes after renal transplantation in children. Pediatr Nephrol 17:520-523
53. Merouani A, Lambert M, Delvin EE, Genest J Jr, Robitaille P, Rozen R (2001) Plasma homocysteine concentration in children with chronic renal failure. Pediatr Nephrol 16:805-811
54. Lilien M, Duran M, Van Hoeck K, Poll-The BT, Schroder C (1999) Hyperhomocyst(e)inaemia in children with chronic renal failure. Nephrol Dial Transplant 14:366-368
55. Feinstein S, Sela BA, Drukker A, Becker-Cohen R, Raveh D, Gavendo S, Frishberg Y (2002) Hyperhomocysteinemia in children on renal replacement therapy. Pediatr Nephrol 17:515-519
56. Goldstein SL, Currier H, Watters L, Hempe JM, Sheth RD, Silverstein D (2003) Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 143:653-657
57. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2004) Abnormal carotid artery structure and function in children with successful renal transplant. Circulation 110:97-101
58. Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO (2002) Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int 61:630-637
59. Gulati S, Stephens D, Balfe JA, Secker D, Harvey E, Balfe JW (2001) Children with hypoalbuminemia on continuous peritoneal dialysis are at risk for technique failure. Kidney Int 59:2361-2367
60. Nurmohamed SA, Nube MJ (2005) Reverse epidemiology: Paradoxical observations in haemodialysis patients. Neth J Med 63:376-381, Review
61. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19:1550-1558
62. Swynghedauw B (1999) Molecular mechanisms of myocardial remodeling. Physiol Rev 79:215-262
63. London GM, Parfrey PS (1997) Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther 4:194-211
64. Guerin AP, Adda H, London GM, Marchais SJ (2004) Cardiovascular disease in renal failure. Minerva Urol Nefrol 56:279-288
65. Fuster V, Fallon JT, Badimon JJ, Nemerson Y (1997) The unstable atherosclerotic plaque: Clinical significance and therapeutic intervention. Thromb Haemost 78:247-255, Review
66. Werner N, Nickenig G (2006) Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 10:318-332
67. Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE (1979) Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16:600-611
68. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F (1996) Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50:600-608
69. London GM, Guerin AP (1999) Influence of arterial pulse and reflected waves on blood pressure and cardiac function. Am Heart J 138:220-224
70. Giachelli CM (2004) Vascular calcification mechanisms. J Am Soc Nephrol 15:2959-2964
71. Price PA, Lim JE (2003) The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem 278:22144-22152
72. Price PA, Williamson MK, Nguyen TM, Than TN (2004) Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 279:1594-1600
73. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 361:827-833
74. Jono S, Nishizawa Y, Shioi A, Morii H (1998) 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98:1302-1306
75. Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: An early perspective. Am J Physiol Endocrinol Metab 286:E686-E696
76. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR (1996) Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 50:998-1006
77. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2003) Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864-868
78. Matteucci MC, Wuhl E, Picca S, Mastrostefano A, Rinelli G, Romano C, Rizzoni G, Mehls O, de Simone G, Schaefer F; ESCAPE Trial Group (2006) Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 17:218-226
79. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2006). Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 149:671-675
80. Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF (2001) Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16:318-323
81. Ulinski T, Genty J, Viau C, Tillous-Borde I, Descheous E (2006) Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol 21:1171-1178
82. Morris KP, Skinner JR, Wren C, Hunter S, Coulthard MG (1993) Cardiac abnormalities in end stage renal failure and anaemia. Arch Dis Child 68:637-643
83. O'Regan S, Matina D, Ducharme G, Davignon A (1983) Echocardiographic assessment of cardiac function in children with chronic renal failure. Kidney Int (Suppl 15):77-82
84. Drukker A, Urbach J, Glaser J (1981) Hypertrophic cardiomyopathy in children with end-stage renal disease and hypertension. Proc Eur Transplant Assoc 18:542-547
85. Palcoux JB, Palcoux MC, Jouan JP, Gourgand JM, Cassagnes J, Malpuech G (1982) Echocardiographic patterns in infants and children with chronic renal failure. Int J Pediatr Nephrol 3:311-314
86. Litwin M, Grenda R, Prokurat S, Abuauba M, Latoszynska J, Jobs K, Boguszewska-Baczkowska A, Wawer ZT (2001) Patient survival and causes of death on hemodialysis and peritoneal dialysis-single-center study. Pediatr Nephrol 16:996-1001
87. Matteucci MG, Giordano U, Calzolari A, Turchetta A, Santilli A, Rizzoni G (1999) Left ventricular hypertrophy, treadmill tests, and 24-h blood pressure in pediatric transplant patients. Kidney Int 56:1566-1570
88. Mitsnefes MM, Schwartz SM, Daniels SR, Kimball TR, Khoury P, Strife CF (2001) Changes in left ventricular mass in children and adolescents after renal transplantation. Pediatr Transplant 5:279-284
89. Morgan H, Khan I, Hashmi A, Hebert D, McCrindle BW, Balfe JW (2001) Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol 16:843-847
90. El-Husseini AA, Sheashaa HA, Hassan NA, El-Demerdash FM, Sobh MA, Ghoneim MA (2004) Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation. Pediatr Transplant 8:249-254
91. Kitzmueller E, Vecsei A, Pichler J, Bohm M, Muller T, Vargha R, Csaicsich D, Aufricht C (2004) Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol 19:1385-1389
92. Englund M, Berg U, Tyden G (2003) A longitudinal study of children who received renal transplants 10-20 years ago. Transplantation 76:311-318
93. Levin A, Djurdjev O, Thompson C, Barrett B, Ethier J, Carlisle E, Barre P, Magner P, Muirhead N, Tobe S, Tam P, Wadgymar JA, Kappel J, Holland D, Pichette V, Shoker A, Soltys G, Verrelli M, Singer J (2005) Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 46:799-811
94. Foley RN, Parfrey PS, Morgan J, Barre PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA (2000) Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 58:1325-1335
95. Paoletti E, Cassottana P, Bellino D, Specchia C, Messa P, Cannella G (2002) Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 40:728-736
96. Roger SD, McMahon LP, Clarkson A, Disney A, Harris D, Hawley C, Healy H, Kerr P, Lynn K, Parnham A, Pascoe R, Voss D, Walker R, Levin A (2004) Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial. J Am Soc Nephrol 15:148-156
97. Morris KP, Skinner JR, Hunter S, Coulthard MG (1994) Cardiovascular abnormalities in end stage renal failure: The effect of anaemia or uraemia? Arch Dis Child 71:119-122
98. London GM, De Vernejoul MC, Fabiani F, Marchais SJ, Guerin AP, Metivier F, London AM, Llach F (1987) Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32:900-907
99. Rostand SG, Drueke TB (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56:383-392
100. Bogin E, Massry SG, Harary I (1981) Effect of parathyroid hormone on rat heart cells. J Clin Invest 67:1215-1227
101. Katoh Y, Klein KL, Kaplan RA, Sanborn WG, Kurokawa K (1981) Parathyroid hormone has a positive inotropic action in the rat. Endocrinology 109:2252
102. Colan SD, Sanders SP, Ingelfinger JR, Harmon W (1987) Left ventricular mechanics and contractile state in children and adolescents with end-stage renal disease: Effect of dialysis and renal transplantation. J Am Coll Cardiol 10:1085-1094
103. Goren A, Glaser J, Drukker A (1993) Diastolic function in children and adolescents on dialysis and after kidney transplantation: An echocardiographic assessment. Pediatr Nephrol 7:725-728
104. Colan SD, Borow KM, Neuman A (1984) Left ventricular end-systolic wall stress-velocity of fiber shortening relation: A load independent index of myocardial contractility. J Am Coll Cardiol 4:715-724
105. Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2004) Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 1461-1466
106. Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2004) Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis 43:721-726
107. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740
108. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM (1998) Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570-574
109. Groothoff JW, Gruppen MP, Offringa M, de Groot E, Stok W, Bos WJ, Davin JC, Lilien MR, Van de Kar NC, Wolff ED, Heymans HS (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13:2953-2961
110. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483
111. Milliner DS, Zinsmeister AR, Lieberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931-936
112. Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426-1433
113. Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906-1914
114. Dursun H, Kucukosmanoglu O, Noyan A, Ozbarlas N, Buyukcelik M, Soran M, Bayazit AK, Anarat A (2005) Mitral annular calcification and brown tumor of the rib in a child with chronic renal failure. Pediatr Nephrol 20:673-675
115. Nayir A, Bilge I, Kilicaslan I, Ander H, Emre S, Sirin A (2001) Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 6:2041-2047
116. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2005) Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: Role of calcium-phosphorus metabolism. J Am Soc Nephrol 16:2796-2803
117. Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494-1500
118. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
119. London GM, Pannier B, Agharazii M, Guerin AP, Verbeke FH, Marchais SJ (2004) Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int 65:700-704
120. Kari JA, Donald AE, Vallance DT, Bruckdorfer KR, Leone A, Mullen MJ, Bunce T, Dorado B, Deanfield JE, Rees L (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52:468-472
121. Lilien MR, Koomans HA, Schroder CH (2005) Hemodialysis acutely impairs endothelial function in children. Pediatr Nephrol 20:200-204
122. Lilien MR, Stroes ES, Op't Roodt J, de Jongh S, Schroder CH, Koomans HA (2003) Vascular function in children after renal transplantation. Am J Kidney Dis 41:684-691
123. K/DOQI, National Kidney Foundation (2006) III Clinical practice recommendations for anemia in chronic kidney disease in children. Am J Kidney Dis 47(Suppl 3):S86-S109
124. (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576